FDA Investigator Jennifer Lalama

Jennifer Lalama has inspections in 9 countries as of 29 Sep 2023. Jennifer Lalama has collaborated with a combinined 5055 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
120
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100004241
Country:
United States of America, Spain, Denmark, Japan, France, Italy, Germany, United Kingdom of Great Britain and Northern Ireland, India
Co-Investigator(s):
Aaron F Coleman, Adalberto Cajigas, Adaliz Santaliz Cruz, Adam R Cooke, Alan A Rivera, Albert A Salvador, Alexander B Anderson, Amanda E Lewin, PhD, Ana P Barido, Anabel Veiga, Andrea Dcharles Julien, Andrea George, PhD, Andrew J Mcguffin, Ariel Cruz Figueroa, Arlene M Badillo, Arsen Karapetyan, Arthur G Hurst, Ashley N Queen, PhD, Azza Talaat, Barbara D Wright, Benita C Okeke, Bill Tacket, Jr, Bonita S Chester, Brandon C Heitmeier, Brittny C Cargo, Bruce H Mccullough, Brunilda Torres, Calvin B Koerner, Carl Lee, Caroline Strasinger, CDR Ileana Barreto Pettit, Charles D Brown, Charles I Ann, Cheryl A Clausen, Christie A Garcia, Christie A Soto, Christopher Downey, PhD, Christos G Tsingelis, Clara E Santiago, Clinton J Lott, Colleen Thomas, PhD, Courtney A Gilbert, Craig A Garmendia, Damaris Y Hernandez, Daryl A Dewoskin, David P King, Dawn M Mccabe, Denise M Digiulio, Dennis Cantellops Paite, Devaughn Edwards, Diane L Raccasi, Diane P Goyette, Dianiris C Ayala, Dillard H Woody, Jr, Dipti Kalra, Donald C Obenhuber, PhD, Dorothy P Kramer, Dov Pluznik, PhD, Dr. Carmelo Rosa, Dr. Dominick Roselle, Dr. Ralph M Bernstein, PhD, Dusty F Snoeberg, Earl Echon, Edmund F Mrak, Jr, Eduardo Carbonell, Edward H Maticka, Edwards, Edwin J Gorney, Eliezar Ramos, Erika V Butler, Felix Maldonado, Frank W Perrella, Gabriel E Muniz, George J Flynn, Gerard Pde Leon, German Rivera, Gregory Price, Haley H Seymour, Harshal J Desai, Heather M Bullock, Hunt, Ian F Deveau, Ivis Lnegron Torres, James L Dunnie, Jr, James To Neal, Jamirya S Weatherly, Jawaid Hamid, Jennifer A Robinson, Jennifer D Hollstrom, Jennifer L Bridgewater, Jennifer L Huntington, Jennifer M Menendez, Jerri Baker, Jessica L Pressley, Jessica M Simpson, Jingbo Xiao, Joanne E King, Jogy George, John J Bernal, Jorge L Lajara, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Martinez, Jr, Jose Perez Soto, Jose R Hernandez, Jose R Lopez, Jose Velez, Joshua J Silvestri, Julian C Hanson, June P Page, Justin A Boyd, Justine Tomasso, Karen M Rodriguez, Karen Takahashi, Karl D Hezel, Kayla V Sprague, Kelly M Byers, Kemejumaka N Opara, Kevin T Nguyen, Kirtida Patel, Ladislav Kermet, Lareese K Thomas, Larry K Hampton, Latorie S Jones, Laura D Cain, Laura Fontan, MS, Laura L Staples, Laurie Nelson, LCDR Angelica M Chica, LCDR Chad N Thompson, LCDR Michael H Tollon, LCDR Randall L Morris, Libia M Lugo, Lillian Mcolon Mcknight, Linda K Matheny, Lindsey M Schwierjohann, Lissette Paiz, Lourdes Andujar, LT Daveta L Bailey, LT Kimberly M Hull, LT Rafael Gonzalez, LT Richard A Lyght, LT Tamara J Henderson, Lucas B Leake, Luis M Burgos Medero, Lura D Baquero, Luz I Collado, Lynne Ensor, Marc Balzarini, Marcus A Ray, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marie F Morin, Marinee Flores Marrero, Martrice A Packer, Marvin D Jones, Massoud Motamed, Matthew F Duff, Maxwell Van Tassell, PhD, Megan K Otero, Megan T Ziegler, Melanie G Warzala, Melanie W Pishnery, Mendoza, Meredith P Soehl, Investigator, Michael A Charles, Michael C Lombardi, Michael Shanks, MS, Michele L Obert, Michele Perry Williams, Michelle S Dunaway, Michelle Y Clark Stuart, Miguel A Martinez, Milva E Melendez, Milva Emelendez Perales, Misty L Treece, Mizanne E Lewis, Moraima J Ramos Valle, Myriam M Sosa, Nancy G Schmidt, Naveen B Kanthamneni, Nicholas Obiri, PhD, Nicolas Riveratorres, Nicole E Knowlton, Nikolay Spiridonov, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Omayra Nrodriguez Ruiz, Omotunde O Osunsanmi, Ormond, Parul M Patel, Patricia Fhughes Troost, Patrick E Gainer, Paul E Stein, Paul L Figarole, Jr, Paul Z Balcer, Paula A Trost, Philip F Istafanos, DMV, MS, Philippa Hillyer, Rachel A Gomez, Rachel A Peters, Rachel C Harrington, Rafael E Arroyo, Ramesh Potla, PhD, Ramon A Hernandez, Raymond A Lyn, Jr, Raymond T Oji, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regan T Harp, Regina T Brown, Reynolds, Richard H Penta, Riley C Myers, PhD, Rina Bhikha, Robert C Coleman, Robert D Tollefsen, Robert Darius, Ronald Ifraimov, Rosario D'costa, Roy R Rinc, Rozelle G Smith, Rumany C Penn, PharmD, Russell J Glapion, Ruth A Williams, Saied A Asbagh, Saleem A Akhtar, Salvatore N Randazzo, Samina S Khan, Sarah E Mcmullen, Sarah Ibrahim, Saundrea A Munroe, Scott B Laufenberg, Scott R Izyk, Scott T Ballard, Seneca D Toms, Sergio E Delgado, Sharon Giamberini, Shavon L Square, Shelby N Marler, Shelby N Turner, Sixto M Mercado Rios, Sonya M Edmonds, Sripal R Mada, PhD, Stacey F Allard, Stacey F Rivette, State Agency, Stephanie D Crockett, Steven A Brettler, Steven C Madzo, Steven D Dittert, Steven Fong, MS, PhD, Steven J Rush, Susan M Turcovski, Suzanne N Vallez, Tamara M Casselman, Tammara A Stephens, Ted L Anderson, Teresa I Navas, Thomas J Arista, Timothy Wadkin, PhD, Torrance J Slayton, Tracy J Washington, Victor Spanioli, Vilmary Negron Rodriguez, Virginia L Meeks, Vivin George, Wayne S Fortenberry, Wendy G Tan, PhD, William J Leonard, Xiujing L Baggett, Yifan Wang, Youmin Wang, Zachary L Stamm, Zada L Giles, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Jennifer Lalama's Documents

Publish Date Document Type Title
February, 2022 FDA 483 Ionetix Corporation - Form 483, 2022-02-09
July, 2019 FDA 483 Aveva Drug Delivery Systems Inc. - Form 483, 2019-07-26
March, 2016 FDA 483 Custom Meds, Inc. - Form 483, 2016-03-25
April, 2014 FDA 483 Prime Packaging - Form 483, 2014-04-29
May, 2016 FDA 483 Belcher Pharmaceuticals, LLC - Form 483, 2016-05-13
September, 2017 FDA 483 Eisai Co., Ltd. - Form 483, 2017-09-15
June, 2018 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2018-06-14
January, 2020 FDA 483 Atlantic Biologicals - Form 483, 2020-01-14
September, 2019 FDA 483 Interquim, S.A. - Form 483, 2019-09-27
November, 2015 FDA 483 A.I.G. TECHNOLOGIES, INC. - Form 483, 2015-11-17
July, 2018 FDA 483 ICROM SRL - Form 483, 2018-07-20
July, 2022 FDA 483 Airgas Usa, LLC - Form 483, 2022-07-22
December, 2022 FDA 483 RAPHA HEALTH NETWORK INTERNATIONAL INC - Form 483, 2022-12-16
August, 2018 FDA 483 Horizon Pharmaceuticals , Inc. - Form 483, 2018-08-17
September, 2022 FDA 483 Dharma Research, Inc. - Form 483, 2022-09-30
March, 2016 EIR Pharmatech LLC - EIR, 2016-03-02
March, 2020 FDA 483 Response CORERX, INC. - Form 483R, 2020-03-27
October, 2014 FDA 483 Kramer Laboratories, Inc. - Form 483, 2014-10-14
July, 2017 FDA 483 LEESAR, INC - Form 483, 2017-07-12
May, 2016 EIR Belcher Pharmaceuticals, LLC - EIR, 2016-05-13
July, 2015 FDA 483 Noven Pharmaceuticals, Inc. - Form 483, 2015-07-10
August, 2017 FDA 483 Horizon Pharmaceuticals , Inc. - Form 483, 2017-08-05
April, 2013 EIR David H. Flaherty - EIR, 2013-04-01
November, 2017 FDA 483 Response Cerno Pharmaceutical - Form 483R, 2017-12-13
June, 2022 FDA 483 Response USpharma Ltd - Form 483R, 2022-06-23
April, 2016 FDA 483 GADAL Laboratories, Inc - Form 483, 2016-04-28
December, 2019 FDA 483 SOFGEN PHARMACEUTICALS LLC - Form 483, 2019-12-11
July, 2017 FDA 483 Vital Rx, Inc. dba Atlantic Pharmacy and Compounding - Form 483, 2017-07-20
November, 2019 FDA 483 All Pharma, LLC - Form 483, 2019-11-15
January, 2018 EIR Allay Pharmaceuticals, LLC - EIR, 2018-01-17
October, 2017 FDA 483 KRS Global Biotechnology, Inc - Form 483, 2017-10-23
November, 2017 FDA 483 Cerno Pharmaceutical - Form 483, 2017-11-17
June, 2019 FDA 483 Pharmalab Enterprises, Inc. - Form 483, 2019-06-17
October, 2021 FDA 483 LEESAR, INC - Form 483, 2021-10-29
April, 2012 FDA 483 Natural Vitamins Laboratory Corp. - Form 483, 2012-04-03
August, 2016 FDA 483 Pharmatech LLC - Form 483, 2016-08-09
September, 2018 FDA 483 Debut Development LLC - Form 483, 2018-09-20
February, 2019 FDA 483 Chemco Corporation - Form 483, 2019-02-12
January, 2016 FDA 483 Drug Depot, LLC., dba APS Pharmacy - Form 483, 2016-01-22
September, 2021 FDA 483 PLD Acquisitions LLC D/B/A Avema Pharma Solutions - Form 483, 2021-09-21
May, 2017 FDA 483 DNA Pharmacy Services Inc dba Palm Beach Compounding - Form 483, 2017-05-23
July, 2018 EIR ICROM SRL - EIR, 2018-07-20
April, 2019 EIR Amgen Manufacturing Ltd - EIR, 2019-04-11
November, 2016 FDA 483 ECI Pharmaceuticals LLC - Form 483, 2016-11-18
October, 2018 FDA 483 Cardinal Health 414, LLC - Form 483, 2018-10-26
November, 2018 FDA 483 World Perfumes Inc - Form 483, 2018-11-20
October, 2022 FDA 483 Chemco Corporation - Form 483, 2022-10-31
May, 2017 FDA 483 Pharmatech LLC - Form 483, 2017-05-02
April, 2019 FDA 483 Amgen Manufacturing Ltd - Form 483, 2019-04-11
April, 2013 FDA 483 David H. Flaherty - Form 483, 2013-03-20
March, 2020 EIR CORERX, INC. - EIR, 2020-03-06
August, 2016 FDA 483 Response Pharmatech LLC - Form 483R, 2016-08-25
November, 2015 FDA 483 Response A.I.G. TECHNOLOGIES, INC. - Form 483R, 2015-12-02
May, 2022 FDA 483 Delta Pharma, Inc. - Form 483, 2022-05-20
March, 2020 FDA 483 CORERX, INC. - Form 483, 2020-03-06
November, 2015 EIR A.I.G. TECHNOLOGIES, INC. - EIR, 2015-11-17
June, 2022 FDA 483 USpharma Ltd - Form 483, 2022-06-23
September, 2017 FDA 483 Spera Nexus, Inc. - Form 483, 2017-09-07
June, 2022 EIR USpharma Ltd - EIR, 2022-06-23
August, 2018 FDA 483 Laboratorios Quantium Llc - Form 483, 2018-08-02
August, 2022 FDA 483 Infusion Systems of SW Florida Inc. dba Myerlee Pharmacy - Form 483, 2022-08-11
November, 2021 FDA 483 Noven Pharmaceuticals, Inc. - Form 483, 2021-11-17
September, 2019 FDA 483 DermaPharm A/S - Form 483, 2019-09-19
August, 2019 FDA 483 O.L. PRODUCTS, INC. - Form 483, 2019-08-14
February, 2020 FDA 483 Applied Consumer Services, Inc. - Form 483, 2020-02-21
March, 2018 FDA 483 Pure Source, LLC - Form 483, 2018-03-01
April, 2019 FDA 483 Response Amgen Manufacturing Ltd - Form 483R, 2019-04-29
July, 2017 FDA 483 Infusion Systems of SW Florida Inc. dba Myerlee Pharmacy - Form 483, 2017-07-20
September, 2021 FDA 483 Hybrid Pharma LLC - Form 483, 2021-09-03

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more